title: Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.
abstract: Oncostatin M (OSM), an inflammatory cytokine of the interleukin-6 (IL-6) superfamily, plays a key role in various biological processes such as modulation of extracellular matrix (ECM), cell proliferation, cell survival, and induction of inflammation. It has been reported that OSM was increased in asthma and pulmonary fibrosis, and thus OSM may play a role in airway remodeling and the development of lung parenchymal fibrosis. Recruitment of lung fibroblasts to the sites of airway injury and subsequent differentiation into myofibroblasts is believed to contribute to excess ECM deposition. In the current study, we assessed the ability of OSM to modulate fibroblast collagen gel contraction, migration toward fibronectin, and expression of α-smooth muscle actin (α-SMA). We demonstrated that OSM augments gel contraction, chemotaxis, and α-SMA expression. OSM-augmented fibroblast chemotaxis was mediated by the signal transducer and activator of transcription (STAT3) and p38 mitogen-activated protein kinase, while augmentation on gel contraction and α-SMA expression was mediated by STAT3. Neither transforming growth factor-β1 nor PGE2 was involved in mediating OSM effect on the cells. The Th2 cytokines IL-4 and IL-13, which also are believed to play an important role in promoting lung fibrosis and airway remodeling, act through STAT3, and we demonstrated the potential for additive effects of OSM with IL-4 and IL-13. The present study supports the concept that OSM may contribute to tissue remodeling, which may be additive with IL-4 or IL-13. Blockade of OSM or OSM-mediated STAT3 signaling could be a therapeutic target to regulate lung fibrotic mechanisms.
authors.affiliation: 1 Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Kumi Yoneda
authors.initials: KY
authors.lastname: Nagahama
authors.forename: Shinsaku
authors.initials: S
authors.lastname: Togo
authors.forename: Olaf
authors.initials: O
authors.lastname: Holz
authors.forename: Helgo
authors.initials: H
authors.lastname: Magnussen
authors.forename: Xiangde
authors.initials: X
authors.lastname: Liu
authors.forename: Kuniaki
authors.initials: K
authors.lastname: Seyama
authors.forename: Kazuhisa
authors.initials: K
authors.lastname: Takahashi
authors.forename: Stephen I
authors.initials: SI
authors.lastname: Rennard
mesh_terms: D000199:Actins / Q000378:metabolism; D002478:Cells, Cultured; D002633:Chemotaxis / Q000187:drug effects; D003094:Collagen / Q000378:metabolism; D005347:Fibroblasts; D005353:Fibronectins / Q000378:metabolism; D006801:Humans; D018793:Interleukin-13 / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D053612:Janus Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D053683:Oncostatin M / Q000378:metabolism* / Q000494:pharmacology; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects; D053773:Transforming Growth Factor beta1 / Q000378:metabolism
chemical_list: C541116:ACTA2 protein, human; D000199:Actins; D005353:Fibronectins; D018793:Interleukin-13; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D053773:Transforming Growth Factor beta1; D053683:Oncostatin M; D015847:Interleukin-4; D003094:Collagen; D053612:Janus Kinases; D020928:Mitogen-Activated Protein Kinases